BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $443,626 | -14.6% | 18,446 | +13.4% | 0.00% | 0.0% |
| Q2 2023 | $519,437 | +3.9% | 16,268 | -0.4% | 0.00% | 0.0% |
| Q1 2023 | $500,178 | -19.5% | 16,335 | +2.9% | 0.00% | -33.3% |
| Q4 2022 | $621,106 | -14.7% | 15,881 | +4.0% | 0.01% | -25.0% |
| Q3 2022 | $728,000 | +27.3% | 15,276 | +3.4% | 0.01% | +33.3% |
| Q2 2022 | $572,000 | +8.3% | 14,772 | +60.4% | 0.01% | +50.0% |
| Q1 2022 | $528,000 | -25.8% | 9,209 | +3.1% | 0.00% | -20.0% |
| Q4 2021 | $712,000 | -4.0% | 8,929 | +4.8% | 0.01% | -16.7% |
| Q3 2021 | $742,000 | -30.7% | 8,523 | +2.4% | 0.01% | -33.3% |
| Q2 2021 | $1,071,000 | +164.4% | 8,320 | +64.4% | 0.01% | +125.0% |
| Q1 2021 | $405,000 | +0.7% | 5,062 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $402,000 | – | 4,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HSG Holding Ltd | 1,127,934 | $31,582,000 | 5.60% |
| Omega Fund Management, LLC | 302,821 | $8,479,000 | 2.32% |
| Redmile Group, LLC | 3,356,958 | $93,995,000 | 1.74% |
| BRANDYWINE MANAGERS, LLC | 10,875 | $305,000 | 1.25% |
| DC Investments Management, LLC | 88,100 | $2,467,000 | 0.91% |
| Alphabet Inc. | 663,691 | $18,583,000 | 0.86% |
| Cormorant Asset Management, LP | 796,429 | $22,036,000 | 0.84% |
| HHLR ADVISORS, LTD. | 2,966,403 | $83,059,000 | 0.76% |
| Temasek Holdings (Private) Ltd | 3,354,641 | $93,930,000 | 0.56% |
| Granahan Investment Management | 96,598 | $2,705,000 | 0.10% |